Company Filing History:
Years Active: 2019
Title: Innovations of Jonathan Sutton in Cardiovascular Treatment
Introduction
Jonathan Sutton is an accomplished inventor based in Cincinnati, OH. He has made significant contributions to the field of cardiovascular treatment through his innovative work. His research focuses on the development of bioactive gas-encapsulated echogenic liposomes, which have the potential to revolutionize how cardiovascular diseases are treated.
Latest Patents
Jonathan Sutton holds a patent for "Bioactive gas-encapsulated echogenic liposomes and methods for treating cardiovascular disease." This patent describes echogenic liposomes (ELIP) that are formulated with a partially pegylated phospholipid bi-layer shell, encapsulated nitric oxide, and encapsulated perfluorocarbon in a specific volume ratio. The invention outlines methods for treating patients suffering from cardiovascular disease by administering the ELIP at a site remote from the target diseased section. The presence of the ELIP is monitored at the target site, and ultrasound is administered upon detection, allowing for the release of bioactive nitric oxide at the diseased section.
Career Highlights
Jonathan Sutton is affiliated with the University of Cincinnati, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on patient care and treatment outcomes in cardiovascular health.
Collaborations
Some of Jonathan's notable coworkers include Christy Holland and Jason Raymond. Their collaborative efforts contribute to the ongoing research and development in the field of cardiovascular treatments.
Conclusion
Jonathan Sutton's innovative work in developing bioactive gas-encapsulated echogenic liposomes represents a significant advancement in the treatment of cardiovascular disease. His contributions are paving the way for new therapeutic approaches that could improve patient outcomes.